Clinical Trials Browser

Completed × Liver Diseases × Sorafenib × Clear all

NCT04518852 2024-06-25

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Phase 2 Completed

Gastrointestinal

Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT02292173 2021-06-10

Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer

Phase 1 Completed

Gastrointestinal

Digestive System Diseases, Liver Diseases, Liver Neoplasms